Preparation of 131I–betulinic acid and its biodistribution in murine model of hepatocellular tumor

Preclinical Evaluation of an 131I-Labeled Benzamide for Targeted Radiotherapy of Metastatic Melanoma

(2010) J. L. Joyal et al.   CANCER RESEARCH

An experimental study on the antitumor effect of 131I-17-AAG in vitro and in vivo

(2009) Tu Wenyong et al.   ANNALS OF NUCLEAR MEDICINE

Cancer preventive agents 9. Betulinic acid derivatives as potent cancer chemopreventive agents

(2009) Kyoko Nakagawa-Goto et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Targeted radionuclide therapy of melanoma: Anti-tumoural efficacy studies of a new131I labelled potential agent

(2009) Mathilde Bonnet-Duquennoy et al.   INTERNATIONAL JOURNAL OF CANCER

Potential of radioiodinated anticancer compounds of traditional Chinese medicine for cancer therapy

(2009) Min Yang et al.   JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY

A comparative study of 131I and 177Lu labeled somatostatin analogues for therapy of neuroendocrine tumours

(2008) E.B. de Araújo et al.   APPLIED RADIATION AND ISOTOPES

Synthesis and cytotoxic activity of heterocyclic ring-substituted betulinic acid derivatives

(2008) Vivek Kumar et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Betulinic Acid for Cancer Treatment and Prevention

(2008) Simone Fulda   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

131I labeling of tamoxifen and biodistribution studies in rats

(2007) F.Z. Biber Muftuler et al.   APPLIED RADIATION AND ISOTOPES